Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse
Chinmayee Sethy, Kunal Goutam, Deepika Nayak, et al.
Journal of Cancer Research and Clinical Oncology (2019) Vol. 146, Iss. 1, pp. 245-259
Closed Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Nectins and Nectin-like Molecules in Colorectal Cancer: Role in Diagnostics, Prognostic Values, and Emerging Treatment Options: A Literature Review
Jakub Kobecki, Paweł Gajdzis, Grzegorz Mazur, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 11
PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-β in chromatin of breast cancer cells
Chinmayee Sethy, Chanakya Nath Kundu
Toxicology and Applied Pharmacology (2022) Vol. 436, pp. 115860-115860
Closed Access | Times Cited: 10
Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle
Biswajit Das, Chanakya Nath Kundu
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 4, pp. 416-427
Closed Access | Times Cited: 15
High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
Xuequan Wang, Ziming Xing, Huazhong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities—A Systematic Review
Jakub Klekowski, Dorota Zielińska, Adriana Hofman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3983-3983
Open Access | Times Cited: 5
The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors
Andrea Dekanić, Emina Babarović, Paola Kučan Brlić, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154416-154416
Closed Access | Times Cited: 4
Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study
Jakub Kobecki, Paweł Gajdzis, Grzegorz Mazur, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15900-15900
Open Access | Times Cited: 4
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma
Julyanne Brassard, Michael R. Hughes, P.M. Dean, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4
Ching-Hsuan Liu, Sy‐Jye Leu, Chi‐Hsin Lee, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Targeted Therapeutic Strategies for Nectin-4 in Breast Cancer: Recent Advances and Future Prospects
Yufei Wang, Guangliang Li, Han-Ying Wang, et al.
The Breast (2024) Vol. 79, pp. 103838-103838
Open Access | Times Cited: 1
The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition
A. Yu. Kuzevanova, Н. В. Апанович, Danzan Mansorunov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2081-2081
Open Access | Times Cited: 7
Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
Maria Malvina Tsamouri, Thomas M. Steele, Maria Mudryj, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 8
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens
Paul Schossig, Ebru İnci Çoşkun, Ruža Arsenić, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2292-2292
Open Access | Times Cited: 3
Nectin-4 has emerged as a compelling target for breast cancer
Hui Wang, Dejuan Sun, Jinxia Chen, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176129-176129
Closed Access | Times Cited: 3
Nectin-4 regulates cellular senescence-associated enlargement of cell size
Ryoko Katasho, Taiki Nagano, Tetsushi Iwasaki, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Nectin-4: A promising prognostic marker and therapeutic target in cancer
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, et al.
International review of cell and molecular biology (2024), pp. 223-255
Closed Access
Unraveling the Complexity: Expression Patterns and Prognostic Value of Cell Adhesion Junction Regulatory Genes in Hepatocellular Carcinoma
Yuanyang Jin, Yajuan Zhang, Guanghao Xie, et al.
Research Square (Research Square) (2023)
Open Access
Talazoparib enhances the Quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
Chinmay Das, Somya Ranjan Dash, Saptarshi Sinha, et al.
Research Square (Research Square) (2023)
Open Access
Nectin-3 and Nectin-4: potential prognostic biomarkers for therapeutic targeting of cancer
Aihong Yang, Yan Ge, Panpan Yang, et al.
Tropical Journal of Pharmaceutical Research (2023) Vol. 22, Iss. 10, pp. 2235-2241
Open Access
Dynamic, stage-course protein interaction network using high power CpG sites in Head and Neck Squamous Cell Carcinoma
Arsalan Riaz, Maryam Shah, Saad Zaheer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Previous Page - Page 2

Scroll to top